Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Salient Pharma ApS
APS
Active
Advertising protection
CVR 36900709
Naverland 22, 2600
Glostrup
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2015 · 11 years old
1 employees
www.salientpharma.com
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Salient Pharma ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
US
Ulrik Spork
Management
Management
2015
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
SW
Søren Wang Petersen
Board of Directors
Board of Directors
2018
HB
Helle Bøwadt
Board of Directors
Board of Directors
2018
Former (1)
SJ
Søren Johannes Kjær Henningsen
Board of Directors
Board of Directors
2018 – 2025
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
HB-MEDICAL HOLDING ApS
Company
33.33–49.99%
33.33–49.99%
2023
SPORCON LIFESCIENCE ADVISORS ApS
Company
25–33.32%
25–33.32%
2023
CAND.PHARM. POVL M. ASSENS FOND
Company
15–19.99%
15–19.99%
2023
Kjær Henningsen Holding ApS
Company
5–9.99%
5–9.99%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Salient Pharma ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network